AHRI Data Repository
Data Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / AHRI.GCTC.GUIDANCE
central

Knowledge, Practices and Perceptions of Good Clinical Trials Collaborative (GCTC) Guidance in the Conduct of Clinical Trials in South Africa

South Africa, 2024
Get Microdata
Reference ID
AHRI.GCTC.Guidance
Producer(s)
Njabulo Dayi, Andani Ratshinanga, Nompumelelo Mkwanazi, Sweetness Dube, Dickman Gareta, Allanise Cloete, Khethokuhle Nkosi, Londiwe Shandu, Eugene Ehlers, Eugene Prenzler, Brendan Gilbert, Anne Derache, Nompumelelo Ngobese, Limakatso Lebina
Metadata
Documentation in PDF DDI/XML JSON
Created on
Jun 04, 2026
Last modified
Jun 05, 2026
Page views
32
Downloads
19
  • Study Description
  • Downloads
  • Get Microdata
  • Identification
  • Version
  • Scope
  • Coverage
  • Producers and sponsors
  • Sampling
  • Data collection
  • Data processing
  • Data Access
  • Metadata production
  • Identification

    Survey ID number

    AHRI.GCTC.Guidance

    Title

    Knowledge, Practices and Perceptions of Good Clinical Trials Collaborative (GCTC) Guidance in the Conduct of Clinical Trials in South Africa

    Country
    Name Country code
    South Africa ZA
    Abstract

    Participant recruitment and retention, as well as community engagement, are vital to the success of clinical trials, yet they are often approached as procedural rather than relational processes, limiting meaningful interaction between researchers and participants. This paper explores these dynamics as part of a broader initiative assessing knowledge and practice of the Good Clinical Trials Collaborative (GCTC) Guidance among clinical trial stakeholders in South Africa. A convergent parallel mixed-method design was adopted, with this paper focusing on the qualitative component. Purposeful sampling was used to recruit 22 key informants, including clinical trial researchers, regulatory specialists, implementation scientists, and administrative personnel. Data were analysed using thematic analysis to identify patterns and thematic structures, supported by NVivo 15 software for coding, organisation, and retrieval of qualitative data. Findings indicate that effective community engagement is often hindered by poor communication, language barriers, low research literacy, and historical mistrust stemming from past ethical breaches, contributing to misunderstandings and reduced participation. Participants highlighted the importance of transparency, including trial registration and the provision of clear, accessible information, as well as improved, contextually appropriate communication strategies to build trust, facilitate informed consent, and enhance participation. The study underscores persistent challenges related to communication and trust that affect recruitment, retention, and engagement. Addressing these challenges requires transparent, ongoing, and inclusive communication approaches that are sensitive to linguistic and cultural diversity. Strengthening relational, community-centred practices and aligning recruitment and engagement with GCTC Guidance principles are essential for promoting equity, inclusivity, and the conduct of high-quality clinical research in diverse settings such as South Africa.

    Version

    Version Description

    v1.0.0

    Scope

    Topics
    Topic Vocabulary URI
    Clinical Trials as Topic: The overarching field of research, trial registration, and trial conduct. Africa Health Research Institute www.ahri.org
    Patient Selection: Covers participant recruitment, purposeful sampling, and the inclusion/exclusion of research subjects. Africa Health Research Institute www.ahri.org
    Community-Based Participatory Research: Encompasses community engagement, relational processes, and collaborative research Africa Health Research Institute www.ahri.org
    Keywords
    Good Clinical Trials Collaborative (GCTC) Guidance; Community Engagement; Participant Recruitment and Retention; Clinical Trials; Research Literacy; South Africa

    Coverage

    Geographic Coverage

    The dataset covers multiple provinces in South Africa, reflecting a broad geographic spread across key clinical research settings. Participants were drawn from diverse locations, ensuring representation across different provincial contexts.

    Universe

    Characteristic Description

    Population (Universe) Professionals involved in clinical trials
    Geographical Location Mainly South Africa (KZN, Gauteng, Western Cape, Eastern Cape, Free State), with one from the UK
    Age Range Adult participants (approximately 30 years to over 70 years) [
    Gender Both male and female
    Sector of Work Clinical research organizations, academic institutions, research institutes
    Professional Roles Principal investigators, research nurses, consultants, project managers, community engagement officers
    Level of Experience Ranges from 0-4 years to over 20 years in clinical trials
    Field of Study/Expertise Medical science, public health, management, social sciences
    Disease Focus Areas HIV, tuberculosis (TB), vaccines, and other health conditions
    Locality Type Mainly urban, with some peri-urban representation

    Producers and sponsors

    Primary investigators
    Name Affiliation
    Njabulo Dayi AHRI
    Andani Ratshinanga AHRI
    Nompumelelo Mkwanazi AHRI
    Sweetness Dube AHRI
    Dickman Gareta AHRI
    Allanise Cloete AHRI
    Khethokuhle Nkosi AHRI
    Londiwe Shandu AHRI
    Eugene Ehlers AHRI
    Eugene Prenzler AHRI
    Brendan Gilbert AHRI
    Anne Derache AHRI
    Nompumelelo Ngobese AHRI
    Limakatso Lebina AHRI
    Producers
    Name
    Africa Health Research Institute
    Funding Agency/Sponsor
    Name Abbreviation Role
    Wellcome Trust WT Funder

    Sampling

    Sampling Procedure

    All clinical trials conducted in South Africa, along with their locations, are registered in two public online databases: sanctr.samrc.ac.za and Clinicaltrials.gov. These registers, along with Google searches and snowball sampling, were used to identify the major role players in clinical trials in SA. The implementers of clinical trials were categorised as follows: pharmaceutical companies, universities, contract research organisations (CROs), South African sponsors, independent research units, and regulatory organisations. A total of 552 key implementors of clinical trials were identified.

    "Figure 1: Procedures for key informant interviews.

    Of the 552 identified implementers of clinical trials, 105 were invited to participate in in-depth interviews. The ICF was shared with potential participants via Research Electronic Data Capture (REDCap) before their scheduled interviews. Briefly, REDCap is a secure, web-based software platform designed to support data capture for research studies, providing 1) an intuitive interface for validated data capture; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for data integration and interoperability with external sources.. The interviews were conducted either in person or via Microsoft Teams and were recorded. A semi-structured interview guide, along with a brief demographic questionnaire, was used to collect information from key stakeholders on the implementation of clinical trials in South Africa, including their experiences, the regulatory framework, laboratory and pharmacy infrastructure, clinical trial monitoring, and community perceptions. A total of 22 in-depth interviews
    were conducted"

    Data collection

    Dates of Data Collection
    Start End
    2024-09-01 2024-11-30

    Data processing

    Data Editing

    Qualitative interviews were audio-recorded and transcribed by the research team. All interviews were in English; therefore, translation of interviews was not required. Thematic analysis was used by reading through the transcripts, and codes were generated.

    Both analyses used NVivo, a computer software program that allows researchers to manage, analyse, and visualise qualitative data and documents systematically and individually, as a tool to assist in generating the themes and codes.
    Used to indicate additional information about the methodology and processing involved in the production of the dataset.

    The raw images have been stripped of the GPS coordinates and index data is completely anonymised.

    Data Access

    Access conditions

    Access to the data requires accurate completion of the online data access application form accessible on the AHRI Data repository(https://data.ahri.org/). Data users are required to abide by the data use conditions stipulated on the application for access to the data. Failure to do so may result in their data access privileges revolved by the Data Custodian. In order to recognise the effort and intellectual contributions of AHRI investigators in producing and curating the data, users of AHRI data must acknowledge the source of the data and abide by the terms and conditions under which the data is accessed. All analytical datasets published on the AHRI Data Repository are assigned digital object identifier (DOIs) and the DOIs can be found on the Data Repository under Study Description tab - Access policy. AHRI data users are required to always cite the dataset using the DOI.

    Citation requirements

    Dayi, N., Ratshinanga, A., Mkwanazi, N., Dube, S., Gareta, D., Cloete, A., Nkosi, K., Shandu, L., Ehlers, E., Prenzler, E., Gilbert, B., Derache, A., Ngobese, N., & Lebina, L. (2026). Knowledge, Practices and Perceptions of Good Clinical Trials Collaborative (GCTC) Guidance in the Conduct of Clinical Trials in South Africa [Dataset]. Africa Health Research Institute.

    DOI: https://doi.org/10.23664/AHRI.GCTC.GUIDANCE

    Metadata production

    DDI Document ID

    AHRI.GCTC.Guidance

    Producers
    Name Abbreviation
    Africa Health Research Institute AHRI
    Back to Catalog
    AHRI Data Repository

    © AHRI Data Repository, All Rights Reserved.